Life Sciences Market Update, Q1 2026

The report covers the following key points and more:

• Growth: Median TTM revenue growth improved to 3.9% in Q1 2026, up from 0.1% in Q1 2025, while total median revenue increased to $636M
• Activity: Global life sciences and healthcare M&A reached 299 deals in March 2026, with $66B of monthly deal value, showing a rebound from February
• Public Market Standouts: The WCP Life Sciences Index rose 6.0% since September 2025, outperforming the S&P 500, which declined 2.4% over the same period
• Buyer Mix: Strategic buyers represented the majority of 2026 YTD M&A activity, with public strategics leading the Q1 buyer mix.
• Venture: Life sciences venture funding reached $15.0B in Q1 2026, above Q1 2025 and broadly consistent with the improved funding environment seen through 2025

Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M -$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.

Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at [email protected].